FdaApplication

NDA 211349

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASTELLAS PHARMA US INC
application_typeNDA
approval_date2018-11-28

Products (1)

ProductActive ingredientStrengthDosage form
XOSPATAGILTERITINIB FUMARATEEQ 40MG BASETABLET;ORAL

1 product